The Lung Cancer Research Foundation (LCRF) is committed to advancing research that will lead to improved detection, treatment, and survival for lung cancer patients. In 2025, LCRF is offering three prestigious research grants, each providing $150,000 in funding over two years to support innovative projects in lung cancer research. These grants are designed for post-doctoral researchers, clinical fellows, and early- to mid-career investigators with less than ten years of faculty experience.
If you’re a researcher looking to make a difference in the fight against lung cancer, this is your chance to secure funding for your groundbreaking work!
LCRF Leading Edge Research Grant
The LCRF Leading Edge Research Grant funds innovative projects that explore the full spectrum of lung cancer research, including:
Lung Cancer Biology – Understanding tumor development and progression.
Biomarker Discovery – Identification of new diagnostic and predictive biomarkers.
Machine Learning & Digital Pathology – Leveraging AI for lung cancer diagnosis.
Next-Generation Therapies – Developing effective, less toxic treatments (targeted therapies, immunotherapies, antibody drug conjugates, cellular therapies, etc.).
Gene-Environment Interactions – Investigating the impact of genetics and environmental factors on lung cancer.
Disparities & Social Determinants of Health – Addressing health inequalities in lung cancer care and outcomes.
Bioengineering Solutions – Innovations in nanotechnology, theranostics, biomaterials, and controlled drug release for lung cancer treatment.
Supportive & Palliative Care – Enhancing the quality of life for lung cancer patients and their families through telemedicine and symptom management.
Key Deadlines:
- Letter of Intent (LOI) Submission: March 3, 2025
- LOI Status Notification: April 18, 2025
- Full Proposal Submission: June 2, 2025
LCRF Research Grant on Prevention and Early Detection
Early detection and prevention are crucial in the fight against lung cancer. This grant funds research aimed at identifying and implementing strategies for early detection, risk stratification, and prevention of lung cancer, including:
Risk Stratification & Screening Uptake – Enhancing patient selection and engagement in lung cancer screening programs.
Biomarkers for NSCLC & SCLC – Developing predictive, diagnostic, and prognostic biomarkers for lung cancer detection.
Liquid Biopsy & Genomic Approaches – Advancing molecular screening for early-stage lung cancer detection.
Imaging & Computational Technologies – Using AI and novel imaging modalities to detect pre-cancerous lesions.
Implementation Science – Translating research findings into practical screening programs to improve early detection.
Pre-Neoplastic Studies – Understanding pre-cancerous changes and progression to lung cancer to develop prevention strategies.
Epidemiology & Risk Factor Studies – Investigating environmental and genetic factors contributing to lung cancer risk.
Key Deadlines:
- Letter of Intent (LOI) Submission: March 3, 2025
- LOI Status Notification: April 18, 2025
- Full Proposal Submission: June 2, 2025
LCRF Research Grant on Overcoming Resistance in Lung Cancer
Resistance to treatment remains one of the biggest challenges in lung cancer care. This grant supports research aimed at understanding, preventing, and overcoming resistance to lung cancer therapies. Key research areas include:
Resistance Mechanisms in Targeted Therapy – Exploring histological transformation, oligometastatic disease, and non-genomic resistance.
Drug Resistance in Therapy – Studying how chemotherapy, immunotherapy, radiotherapy, and antibody drug conjugates contribute to resistance.
Novel Therapeutic Approaches – Developing new treatments to overcome drug resistance.
Diagnostic Biomarkers for Resistance Monitoring – Identifying biomarkers that track treatment response and predict relapse.
Difficult-to-Treat Metastases – Addressing treatment resistance in challenging metastatic sites like brain and leptomeningeal metastases.
Key Deadlines:
- Letter of Intent (LOI) Submission: March 3, 2025
- LOI Status Notification: April 18, 2025
- Full Proposal Submission: June 2, 2025
Who Can Apply?
Eligible Applicants Must:
✔ Be affiliated with a non-profit academic or research institution.
✔ Be a post-doctoral researcher, clinical fellow, or early- to mid-career investigator with less than 10 years since initial faculty appointment.
✔ Submit only one LCRF grant application per grant cycle.
Application Process:
The grants follow a two-step application process:
Letter of Intent (LOI): Applicants submit an LOI summarizing their proposed research.
Full Proposal: Selected applicants from the LOI review stage will be invited to submit a complete proposal.
Why Apply?
Secure $150,000 in funding over two years to support your research.
Join the global fight against lung cancer and contribute to life-saving innovations.
Gain recognition and advance your career as a leading lung cancer researcher.
Apply now and take the next step in transforming lung cancer research!
Visit our main website to see more scholarship and APPLY: https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2025/
Ends On: 3rd March 2025
